Form 4: Baxter International Executive Reports Stock Transaction
SEC Form 4 Filing
Christopher A. Toth, EVP, Group President, Kidney Care at Baxter International, reports disposition of shares to cover tax withholding upon vesting of restricted stock units.
Summary
- On December 31, 2024, Christopher A. Toth, an Executive Vice President at Baxter International Inc., disposed of 32,610 shares of common stock to cover tax obligations.
- The shares were forfeited to cover withholding taxes related to the settlement of vested restricted stock units granted on June 1, 2023.
- The transaction was executed at a price of $29.16 per share.
- Following the transaction, Toth directly owns 183,876 shares of Baxter International Inc.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations from vested stock; it doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of restricted stock units and the subsequent tax obligations, which is a common occurrence for executives.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is related to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| 06/01/2023 | Date of grant for the restricted stock units that vested on December 31, 2024. |
| 12/31/2024 | Date of the transaction where shares were forfeited to cover tax withholding. |
| 01/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.